Hattori Naoko, Komine Mayumi, Yano Shoichiro, Kaneko Takehiko, Hanakawa Yasushi, Hashimoto Koji, Tamaki Kunihiko
Department of Dermatology, Faculty of Medicine, University of Tokyo, and University of Ehime, Japan.
J Invest Dermatol. 2002 Aug;119(2):403-10. doi: 10.1046/j.1523-1747.2002.01843.x.
Keratin K6 is known as an inflammatory and hyperproliferative keratin, and is induced by an inflammatory and hyperproliferative agent. In this study, we demonstrated that interferon-gamma, an antiproliferative agent, also induces keratin K6. We used normal human ex vivo skin, normal human cultured keratinocytes, HaCaT keratinocytes, and DJM cells to examine the induction of K6 by interferon-gamma, by immunohistochemical staining, Western blot analysis, promoter chloramphenicol acetyl transferase assay, and reverse transcriptase polymerase chain reaction of mRNA. We succeeded in demonstrating the induction of keratin K6 by interferon-gamma in ex vivo human skin and HaCaT keratinocytes at the protein and message level, and in cultured normal human keratinocytes at the promoter level. The inhibition of the signal transducing activator of transcription 1 pathway by a dominant-negative transfer gene caused the inhibition of K6 induction by interferon-gamma, and the blocking of nuclear factor kappaB using antisense oligonucleotides also inhibited the K6 induction. We also blocked the released interleukin-1alpha from keratinocytes after stimulation with interferon-gamma by neutralizing antibodies, which showed a decrease in the K6 induction. Our results suggest that a small amount of interleukin-1alpha, which cannot induce K6 by itself, is secreted upon stimulation by interferon-gamma, and that the induction of K6 occurs through the synergistic effect of the interferon-gamma/signal transducing activator of transcription 1 and interleukin-1alpha/nuclear factor kappaB pathways. This is the first report to describe K6 induction in epidermal keratinocytes by interferon-gamma and indicate a probable signal transduction pathway, and demonstrates that K6 is a possible partner of K17 in the inflammatory process.
角蛋白K6是一种炎症性和过度增殖性角蛋白,由炎症性和过度增殖性因子诱导产生。在本研究中,我们发现抗增殖剂γ干扰素也可诱导角蛋白K6。我们使用正常人离体皮肤、正常人培养的角质形成细胞、HaCaT角质形成细胞和DJM细胞,通过免疫组织化学染色、蛋白质印迹分析、启动子氯霉素乙酰转移酶测定以及mRNA的逆转录聚合酶链反应,来检测γ干扰素对角蛋白K6的诱导作用。我们成功证明,γ干扰素可在蛋白质和信息水平上诱导人离体皮肤和HaCaT角质形成细胞中的角蛋白K6,在启动子水平上诱导培养的正常人角质形成细胞中的角蛋白K6。通过显性负性转移基因抑制转录信号转导激活因子1途径,可导致γ干扰素对角蛋白K6诱导作用的抑制,使用反义寡核苷酸阻断核因子κB也可抑制角蛋白K6的诱导。我们还用中和抗体阻断了γ干扰素刺激后角质形成细胞释放的白细胞介素-1α,结果显示角蛋白K6的诱导作用减弱。我们的研究结果表明,少量自身不能诱导角蛋白K6的白细胞介素-1α在γ干扰素刺激后分泌,角蛋白K6的诱导通过γ干扰素/转录信号转导激活因子1和白细胞介素-1α/核因子κB途径的协同作用发生。这是首次报道γ干扰素诱导表皮角质形成细胞中的角蛋白K6,并指出了可能的信号转导途径,证明角蛋白K6在炎症过程中可能是角蛋白K17的伙伴。